DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 47 filers reported holding LUMOS PHARMA INC in Q1 2020. The put-call ratio across all filers is 5.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2021$331,000
-92.4%
33,117
-91.1%
0.01%
-93.5%
Q1 2021$4,365,000
-86.9%
373,117
-60.1%
0.09%
-86.1%
Q4 2020$33,435,000
+158.4%
936,2910.0%0.66%
+109.8%
Q3 2020$12,940,000
-16.2%
936,291
+0.0%
0.32%
-30.0%
Q2 2020$15,437,000
+94.0%
936,1690.0%0.45%
+77.9%
Q1 2020$7,957,000936,1690.25%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders